{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:24:39Z","timestamp":1790889879483,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.neuropharm.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T16:46:31Z","timestamp":1110559591000},"page":"1154-1163","source":"Crossref","is-referenced-by-count":133,"title":["Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies"],"prefix":"10.1016","volume":"48","author":[{"given":"Nissar A.","family":"Darmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo A.","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Sorrentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1526-0968.2002.00452.x","article-title":"Immunomodulation by the autonomic nervous system: therapeutic approach for cancer, collagen diseases, and inflammatory bowel diseases","volume":"6","author":"Abo","year":"2002","journal-title":"Therapeutic Apheresis"},{"issue":"19","key":"10.1016\/j.neuropharm.2005.01.001_bib3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJM199911043411903","article-title":"A comparison of osteopathic spinal manipulation with standard care for patients with low back pain","volume":"341","author":"Andersson","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00001756-200302100-00006","article-title":"Decreased potassium channel IK1 and its regulator neurotrophin-3 (NT-3) in inflamed human bowel","volume":"14","author":"Arnold","year":"2003","journal-title":"Neuroreport"},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(00)00226-0","article-title":"Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat","volume":"396","author":"Beaulieu","year":"2000","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1046\/j.1471-4159.2003.02244.x","article-title":"Massive accumulation of N-acyl-ethanolamines after stroke. Cell signalling in acute cerebral ischemia?","volume":"88","author":"Berger","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.01.001_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00002281-200103000-00006","article-title":"Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain","volume":"13","author":"Borenstein","year":"2001","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","article-title":"Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide","volume":"419","author":"Calignano","year":"2001","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.bjp.0704339","article-title":"Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice","volume":"134","author":"Capasso","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.01.001_bib13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1572-0241.2000.02019.x","article-title":"Multiple organ dysfunction in ulcerative colitis","volume":"95","author":"Caprilli","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor, a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjp.0704466","article-title":"Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat","volume":"135","author":"Conti","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0704900","article-title":"Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems","volume":"137","author":"Costa","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1570159043476963","article-title":"Cannabinoid receptor activation and the endocannabinoid system in the gastrointestinal tract","volume":"2","author":"Coutts","year":"2004","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib18","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(01)02934-9","article-title":"Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors","volume":"506","author":"De Petrocellis","year":"2001","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.neuropharm.2005.01.001_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1472-8206.2002.00094.x","article-title":"Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems","volume":"16","author":"De Petrocellis","year":"2002","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"6507","key":"10.1016\/j.neuropharm.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-2760(98)00042-3","article-title":"\u2018Endocannabinoids\u2019 and other fatty acid derivatives with cannabimimetic properties, biochemistry and possible physiopathological relevance","volume":"1392","author":"Di Marzo","year":"1998","journal-title":"Biochimica et Biophysica Acta: Lipids and Lipid Metabolism"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/0264-6021:3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells","volume":"358","author":"Di Marzo","year":"2001","journal-title":"Biochemical Journal"},{"issue":"6830","key":"10.1016\/j.neuropharm.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.01.001_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/plef.2001.0349","article-title":"Anandamide receptors","volume":"66","author":"Di Marzo","year":"2002","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib26","first-page":"385","article-title":"Synthetic analgesics (II), dithienylbutenyl and dithienylbutylamines","volume":"107","author":"Eddy","year":"1953","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"7","key":"10.1016\/j.neuropharm.2005.01.001_bib27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0028-3908(02)00040-0","article-title":"The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats","volume":"42","author":"Ellington","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib28","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proceedings of the National Academy of Sciences U.S.A."},{"key":"10.1016\/j.neuropharm.2005.01.001_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000542-200103000-00023","article-title":"Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder","volume":"94","author":"Farquhar-Smith","year":"2001","journal-title":"Anesthesiology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.01.001_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0304-3959(01)00419-5","article-title":"Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors","volume":"97","author":"Farquhar-Smith","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0006-2952(01)00712-2","article-title":"Fatty acid amide hydrolase, biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide","volume":"62","author":"Fowler","year":"2001","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib32","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1523\/JNEUROSCI.23-21-07767.2003","article-title":"Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility","volume":"23","author":"Franklin","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(02)02658-4","article-title":"Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice","volume":"457","author":"Gabra","year":"2002","journal-title":"European Journal of Pharmacology"},{"issue":"8954","key":"10.1016\/j.neuropharm.2005.01.001_bib35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(95)90013-6","article-title":"Focal white-matter lesions in brain of patients with inflammatory bowel disease","volume":"345","author":"Geissler","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib36","doi-asserted-by":"crossref","unstructured":"Geppetti, P., Trevisani, M., 2004. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. British Journal of Pharmacology in press (Epub ahead of print).","DOI":"10.1038\/sj.bjp.0705768"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.01.001_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0163-7258(02)00251-6","article-title":"Putative neuroprotective actions of N-acyl-ethanolamines","volume":"95","author":"Hansen","year":"2002","journal-title":"Pharmacology and Therapeutics"},{"issue":"18","key":"10.1016\/j.neuropharm.2005.01.001_bib38","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0024-3205(03)00651-9","article-title":"Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat","volume":"73","author":"Helyes","year":"2003","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib39","doi-asserted-by":"crossref","unstructured":"Hong, S., Wiley, J.W., 2004. Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. Journal of Biological Chemistry in press (Epub ahead of print).","DOI":"10.1074\/jbc.M404167200"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.01.001_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0704293","article-title":"Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation","volume":"134","author":"Izzo","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.01.001_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0016-5085(03)00892-8","article-title":"An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice","volume":"125","author":"Izzo","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","article-title":"The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain","volume":"76","author":"Jaggar","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(98)00621-1","article-title":"The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder","volume":"253","author":"Jaggar","year":"1998","journal-title":"Neuroscience Letters"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2005.01.001_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(01)01059-7","article-title":"Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice","volume":"422","author":"Kamei","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3181\/00379727-208-43860","article-title":"Effects of streptozotocin-induced diabetes and insulin treatment on blood pressure in the male rat","volume":"208","author":"Katovich","year":"1995","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.01.001_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0016-5085(99)70570-6","article-title":"Relapsing ulcerative colitis associated with spinal cord stimulation","volume":"117","author":"Kemler","year":"1999","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.01.001_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.52.5.713","article-title":"Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats","volume":"52","author":"Kihara","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.neuropharm.2005.01.001_bib48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00054725-200307000-00002","article-title":"Expression of protease-activated receptor 2 in ulcerative colitis","volume":"9","author":"Kim","year":"2003","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.01.001_bib49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/abbi.1998.0688","article-title":"Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis","volume":"354","author":"Kondo","year":"1998","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.01.001_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3940(01)01998-X","article-title":"Opioid, cannabinoid and vanilloid receptor localization on porcine cultured myenteric neurons","volume":"308","author":"Kulkarni-Narla","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1388-1981(99)00132-8","article-title":"Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors","volume":"1440","author":"Lambert","year":"1999","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1528-1157.2001.41499.x","article-title":"Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice","volume":"42","author":"Lambert","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/0929867023370707","article-title":"The palmitoylethanolamide family: a new class of anti-inflammatory agents?","volume":"9","author":"Lambert","year":"2002","journal-title":"Current Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.01.001_bib54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0016-5085(03)00881-3","article-title":"Possible endocannabinoid control of colorectal cancer growth","volume":"125","author":"Ligresti","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.01.001_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor PPAR-{alpha} mediates the antiinflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/mcne.2002.1164","article-title":"Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system","volume":"21","author":"Maccarrone","year":"2002","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.01.001_bib57","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/molehr\/8.2.188","article-title":"Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer","volume":"8","author":"Maccarrone","year":"2002","journal-title":"Molecular Human Reproduction"},{"issue":"8","key":"10.1016\/j.neuropharm.2005.01.001_bib58","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI200419465","article-title":"The endogenous cannabinoid system protects against colonic inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib59","first-page":"15","article-title":"N-(2-hydroxyethyl)hexadecanamide reduces mechanical hyperalgesia following sciatic nerve constriction injury","volume":"263","author":"Mazzari","year":"1995","journal-title":"Society of Neuroscience Abstracts"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00015-5","article-title":"N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation","volume":"300","author":"Mazzari","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","article-title":"Endocannabinoids","volume":"359","author":"Mechoulam","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archpedi.157.9.861","article-title":"The use of osteopathic manipulation therapy as an adjuvant for the treatment of recurrent acute otitis media","volume":"157","author":"Mills","year":"2003","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib63","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-2275(20)32041-1","article-title":"Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study","volume":"41","author":"Moesgaard","year":"2000","journal-title":"Journal of Lipid Research"},{"issue":"7","key":"10.1016\/j.neuropharm.2005.01.001_bib64","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1074\/jbc.M306642200","article-title":"Molecular characterization of a phospholipase D generating anandamide and its congeners","volume":"279","author":"Okamoto","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.neuropharm.2005.01.001_bib65","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0016-5085(00)70157-0","article-title":"Brain-gut interactions in ulcerative colitis","volume":"118","author":"Peck","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib66","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.103.050948","article-title":"Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice","volume":"306","author":"Rashid","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6860","key":"10.1016\/j.neuropharm.2005.01.001_bib67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"Rodriguez de Fonseca","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib68","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/00007632-199508150-00013","article-title":"The role of inflammation in lumbar pain","volume":"20","author":"Saal","year":"1995","journal-title":"Spine"},{"issue":"8","key":"10.1016\/j.neuropharm.2005.01.001_bib69","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1161\/01.STR.0000023491.63693.18","article-title":"Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study","volume":"33","author":"Schabitz","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjp.0703328","article-title":"Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats","volume":"130","author":"Shibata","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7827(90)90004-5","article-title":"N-acetylated glycerophospholipids and their derivatives","volume":"29","author":"Schmid","year":"1990","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib72","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jm960752x","article-title":"Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor","volume":"40","author":"Sheskin","year":"1997","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"10.1016\/j.neuropharm.2005.01.001_bib73","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.93.9.3984","article-title":"The ALIAmide palmitoylethanolamide and cannabinoids. but not anandamide. are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons","volume":"93","author":"Skaper","year":"1996","journal-title":"Proceedings of the National Academy of Sciences U.S.A."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.01.001_bib74","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(02)00047-4","article-title":"Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?","volume":"126","author":"Straub","year":"2002","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib75","doi-asserted-by":"crossref","first-page":"35552","DOI":"10.1074\/jbc.M106261200","article-title":"Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance","volume":"276","author":"Ueda","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.neuropharm.2005.01.001_bib76","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/diacare.15.12.1926","article-title":"Diabetic neuropathies","volume":"15","author":"Vinik","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2005.01.001_bib77","series-title":"Foundations for osteopathic medicine","year":"2003"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.01.001_bib78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.10801","article-title":"Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract","volume":"465","author":"Ward","year":"2003","journal-title":"Journal of Comparative Neurology"},{"issue":"12","key":"10.1016\/j.neuropharm.2005.01.001_bib79","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2002.07028.x","article-title":"Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease","volume":"97","author":"Winterkamp","year":"2002","journal-title":"American Journal of Gastroenterology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T21:30:16Z","timestamp":1625607016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0028390805000298"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.01.001","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}